title: Oral ribavirin therapy for subacute sclerosing panencephalitis.
authors.affiliation: Department of Pediatrics, University of Colorado School of Medicine, Denver.
authors.forename: J W
authors.initials: JW
authors.lastname: Ogle
authors.forename: P
authors.initials: P
authors.lastname: Toltzis
authors.forename: W D
authors.initials: WD
authors.lastname: Parker
authors.forename: N
authors.initials: N
authors.lastname: Alvarez
authors.forename: K
authors.initials: K
authors.lastname: McIntosh
authors.forename: M J
authors.initials: MJ
authors.lastname: Levin
authors.forename: B A
authors.initials: BA
authors.lastname: Lauer
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D002648:Child; D005260:Female; D006801:Humans; D008297:Male; D008457:Measles / Q000150:complications*; D012254:Ribavirin / Q000008:administration & dosage / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012263:Ribonucleosides / Q000627:therapeutic use*; D013344:Subacute Sclerosing Panencephalitis / Q000188:drug therapy* / Q000209:etiology
chemical_list: D012263:Ribonucleosides; D012254:Ribavirin